Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.

Kim MJ, Choi NY, Lee EK, Kang MS.

Cell Oncol (Dordr). 2014 Aug;37(4):235-43. doi: 10.1007/s13402-014-0178-4. Epub 2014 Jul 8.

PMID:
25001871
[PubMed - in process]
2.

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.

Breast Cancer Res. 2008;10(4):R69. doi: 10.1186/bcr2131. Epub 2008 Aug 7.

PMID:
18687126
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.

Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.

Acta Oncol. 2011 Jun;50(5):700-10. doi: 10.3109/0284186X.2010.549151. Epub 2011 Jan 24.

PMID:
21261508
[PubMed - indexed for MEDLINE]
4.

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.

Breast Cancer Res Treat. 2011 May;127(1):33-41. doi: 10.1007/s10549-010-0879-y. Epub 2010 Apr 9.

PMID:
20379845
[PubMed - indexed for MEDLINE]
5.

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R.

BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.

PMID:
21129172
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Molecular biomarker analyses using circulating tumor cells.

Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR.

PLoS One. 2010 Sep 8;5(9):e12517. doi: 10.1371/journal.pone.0012517.

PMID:
20838621
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).

Myung JH, Launiere CA, Eddington DT, Hong S.

Langmuir. 2010 Jun 1;26(11):8589-96. doi: 10.1021/la904678p.

PMID:
20155985
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O.

BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.

PMID:
22591372
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.

Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T.

Breast Cancer Res. 2012 Jan 20;14(1):R15.

PMID:
22264265
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Circulating tumor cells and EpCAM expression in neuroendocrine tumors.

Khan MS, Tsigani T, Rashid M, Rabouhans JS, Yu D, Luong TV, Caplin M, Meyer T.

Clin Cancer Res. 2011 Jan 15;17(2):337-45. doi: 10.1158/1078-0432.CCR-10-1776. Epub 2011 Jan 11.

PMID:
21224371
[PubMed - indexed for MEDLINE]
Free Article
11.

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.

Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.

Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.

PMID:
23175471
[PubMed - indexed for MEDLINE]
12.

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.

Obermayr E, Castillo-Tong DC, Pils D, Speiser P, Braicu I, Van Gorp T, Mahner S, Sehouli J, Vergote I, Zeillinger R.

Gynecol Oncol. 2013 Jan;128(1):15-21. doi: 10.1016/j.ygyno.2012.09.021. Epub 2012 Sep 24.

PMID:
23017820
[PubMed - indexed for MEDLINE]
13.

Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q.

Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2.

PMID:
22990361
[PubMed - indexed for MEDLINE]
14.

Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.

Watanabe M, Uehara Y, Yamashita N, Fujimura Y, Nishio K, Sawada T, Takeda K, Koizumi F, Koh Y.

Cytometry A. 2014 Mar;85(3):206-13. doi: 10.1002/cyto.a.22422. Epub 2013 Dec 10.

PMID:
24327318
[PubMed - in process]
15.

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.

Galletti G, Sung MS, Vahdat LT, Shah MA, Santana SM, Altavilla G, Kirby BJ, Giannakakou P.

Lab Chip. 2014 Jan 7;14(1):147-56. doi: 10.1039/c3lc51039e. Epub 2013 Nov 7.

PMID:
24202699
[PubMed - indexed for MEDLINE]
16.

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

Weissenstein U, Schumann A, Reif M, Link S, Toffol-Schmidt UD, Heusser P.

BMC Cancer. 2012 May 30;12:206. doi: 10.1186/1471-2407-12-206.

PMID:
22646670
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.

Sterzynska K, Kempisty B, Zawierucha P, Zabel M.

Folia Histochem Cytobiol. 2012;50(4):534-41. doi: 10.5603/17845.

PMID:
23264216
[PubMed - indexed for MEDLINE]
Free Article
18.

Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.

Antolovic D, Galindo L, Carstens A, Rahbari N, Büchler MW, Weitz J, Koch M.

BMC Biotechnol. 2010 Apr 28;10:35. doi: 10.1186/1472-6750-10-35.

PMID:
20426872
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C.

J Clin Oncol. 2012 Feb 10;30(5):525-32. doi: 10.1200/JCO.2010.33.3716. Epub 2012 Jan 17.

PMID:
22253462
[PubMed - indexed for MEDLINE]
Free Article
20.

Detection of circulating tumor cells in cancers of biliary origin.

Al Ustwani O, Iancu D, Yacoub R, Iyer R.

J Gastrointest Oncol. 2012 Jun;3(2):97-104. doi: 10.3978/j.issn.2078-6891.2011.047.

PMID:
22811877
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk